ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Pediatric rheumatology"

  • Abstract Number: 2152 • ACR Convergence 2025

    Blau Syndrome: features beyond the classic triad and proposal for clinical criteria

    Narendra Bagri1, Nawazish Shaikh2, Manisha jana3, Sushain kalsotra4, Krithika Rajkumar2, Madhumita Roy Chowdhury2, Neerja Gupta2, Danveer Bhadu5, Vishal Gupta2 and Rohan Chawla2, 1All India Institute of Medical Sciences(AIIMS), New Delhi, Delhi, India, 2All India Institute of Medical Sciences, Delhi, Delhi, India, 3ALL INDIA INSTITUTE OF MEDICAL SCIENCES, Delhi, 4All India Institute of Medical Sciences, Delhi, India, 5All India Institute of Medical Sciences, New Delhi, New Delhi, Delhi, India

    Background/Purpose: This study describes the characteristic clinical and radiological findings and outcomes of patients with Blau syndrome from a single tertiary care hospital.Methods: A retrospective…
  • Abstract Number: 2127 • ACR Convergence 2025

    Chronic Non-Bacterial Osteomyelitis of the Petrous Bone: A Case Series

    Jeanine McColl1, Ingrid Goh2, Helen Branson3, Karen Peralta4, Dorsa Aeenfar4, Sharon Cushing3, Rayfel Schneider3 and Ronald laxer5, 1University of Calgary, Calgary, Canada, 2University of Toronto The Hospital for Sick Children, Toronto, ON, Canada, 3University of Toronto The Hospital for Sick Children, Toronto, Canada, 4University of Toronto, The Hospital for Sick Children, Toronto, 5The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Chronic Nonbacterial Osteomyelitis (CNO) is an autoinflammatory disorder of bone usually beginning in children between the ages of 7-12. It typically affects metaphyses of…
  • Abstract Number: 1811 • ACR Convergence 2025

    Pharmacogenomic analysis of prediction of IL-1 Inhibitor treatment response in the CARRA First-line Options for Systemic Juvenile Idiopathic Arthritis Treatment (FROST) Study

    Mariana Correia Marques1, Michael Matt2, Sophia Chou3, Peter Burbelo4, Zuoming Deng5, George Tomlinson6, Yukiko Kimura7, Grant Schulert2 and Michael Ombrello8, 1Translational Genetics and Genomics Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Rockville, MD, 4Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, 5Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 6University of Toronto, Toronto, ON, Canada, 7Hackensack Meridian School of Medicine, New York, NY, 8National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), North Bethesda, MD

    Background/Purpose: Interleukin (IL)-1 inhibitors are now regarded as the first line treatment option for systemic juvenile idiopathic arthritis (sJIA), however in up to half of…
  • Abstract Number: 1669 • ACR Convergence 2025

    Development and Validation of Minimal Disease Activity and Disease Flare for Children with Chronic Nonbacterial Osteomyelitis Using a Consensus and Data-Driven Approach

    Farzana Nuruzzaman1, Natalie Rossenwasser2, Xing Wang3, Ava Klein3, Ian Muse4, Erin Balay-Dustrude5, Megan Nguyen6, Emily Deng3, Jonathan Akikusa7, Matthew Basiaga8, Lindsey Bergstrom9, Fatma Dedeoglu10, Bin Huang11, Jenna King12, Sivia Lapidus13, Tzielan Lee14, Aleksander Lenert15, Cassandra Levesque16, Lillian Lim17, Kimberly Martin18, Elizabeth Murray19, Melissa Oliver20, Karen Onel21, Seza Özen22, Lauren Potts23, Sara M. Stern24, Robin Villaverda25, Eveline Wu26, Ronald laxer27, Polly Ferguson28, Daniel Lovell29 and Yongdong (Dan) Zhao30, 1Stony Brook Children's Hospital, Stony Brook, NY, 2Seattle Children's Hospital, Seattle, WA, 3Seattle Children's Hospital, Seattle, 4University of Washington, Department of Pediatrics, Seattle Children's Hospital, Seattle, 5University of Washington, Seattle, WA, 6Seattle Children’s Research Institute, Seattle, 7The Royal Children's Hospital, Parkville, Victoria, Australia, 8Mayo Clinic, Rochester, MN, 9Patient/parent research partner, Harpswell, ME, 10Boston Children's Hospital, Boston, MA, 11Cincinnati Children's Hospital, Cinciannati, OH, 12Patient/parent Research Partner, Planation, FL, 13Joseph M. Sanzari Children's Hospital, Center for Discovery and Innovation, Hackensack Meridian School of Medicine, Montclair, NJ, 14Stanford University School of Medicine, Palo Alto, CA, 15Iowa Carver College of Medicine, Iowa City, IA, 16Patient/parent research partners, DC district, DC, 17University of Alberta, Edmonton, AB, Canada, 18Patient/parent research partners, Houston, TX, 19Patient/parent research partners, Lynnwood, WA, 20Indiana University, Indianapolis, IN, 21HSS, New York, NY, 22Hacettepe University Medical Faculty, Ankara, Turkey, 23Patient/parent research partners, Santa Cruiz, CA, 24University of Utah, Salt Lake City, UT, 25Patient/parent research partners, Thorton, CO, 26UNC Chapel Hill, Chapel Hill, NC, 27The Hospital for Sick Children, Toronto, ON, Canada, 28University of Iowa Carver College of Medicine, Iowa City, IA, 29Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 30Seattle Children’s Research Institute, Redmond, WA

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an inflammatory bone disease that can result in bone destruction/deformity, persistent bone pain and pathological fractures. Due to the…
  • Abstract Number: 1291 • ACR Convergence 2025

    Gastrointestinal Tract Involvement in Juvenile Systemic Sclerosis: Results from an International Scoping Review of Outcome Measures

    Lauren Robinson1, Lusine Ambartsumyan2, Emily Willis3, Aybuke Gunalp4, Simone Appenzeller5, Ozgur Kasapcopur6, Sarah Ishaq7, Natalia Vasquez Canizares8 and Suzanne Li9, 1Hospital for Special Surgery, New York, NY, 2Seattle Children's Hospital, Seattle, WA, 3Royal Manchester Children's Hospital, Manchester, United Kingdom, 4Cerrahpasa Medicine School, Cerrahpasa, Istanbul, Turkey, 5Unicamp, Campinas, São Paulo, Brazil, 6Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 7Osteopathic Medicine , Touro College of Osteopathic Medicine, New York, NY, 8Children's Hospital at Montefiore, New York, NY, 9Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ

    Background/Purpose: Gastrointestinal (GI) tract involvement is nearly universal in patients with systemic sclerosis (SSc) leading to significant morbidity and mortality. In a North American juvenile…
  • Abstract Number: 1275 • ACR Convergence 2025

    Fostering connections in Pediatric Rheumatology: A Narrative medicine intervention

    Anita Dhanrajani1, Joanne Drew2, Suzanne Edison3, Lakshmi Moorthy4, Ingrid Goh5, Alicia Garceau6, Hanna Saltzman7, Courtney Wells8 and Aviya Levy9, 1Manning Family Children's Hospital, Tulane University Medicine, New Orleans, LA, 2Nationwide Children's Hospital, Columbus, OH, 3Cure JM foundation, Seattle, WA, 4Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 5University of Toronto The Hospital for Sick Children, Toronto, ON, Canada, 6Self Employed, Indianapolis, 7University of Utah, Salt Lake City, UT, 8University of Wisconsin River falls, River Falls, WI, 9Rady Children's Hospital, San Diego, CA

    Background/Purpose: Patients with chronic diseases often report poor health-related quality of life (QOL) and impaired psychosocial functioning. The current model of healthcare in rheumatology emphasizes…
  • Abstract Number: 0422 • ACR Convergence 2025

    Clinical Outcomes of Ultrasound Guidance for Corticosteroid Injections of the Ankle and Midfoot Joints and Tendon Sheaths in Children with Juvenile Idiopathic Arthritis

    Rina Ferguson1, Xing Wang2, Erin Balay-Dustrude3, Ramesh Iyer3, Natalie Rosenwasser1, Susan Shenoi4 and Yongdong (Dan) Zhao5, 1Seattle Children's Hospital, Seattle, WA, 2Seattle Children's Hospital, Seattle, 3University of Washington, Seattle, WA, 4Seattle Children's Hospital and Research Center, Mercer Island, WA, 5Seattle Children’s Research Institute, Redmond, WA

    Background/Purpose: Intra-articular corticosteroid injections (IACI) are used to treat active ankle or midfoot inflammation in juvenile idiopathic arthritis (JIA). Ultrasound (US) can help identify the…
  • Abstract Number: 0397 • ACR Convergence 2025

    Paediatric uveitis – Retrospective comparison of cataract surgery outcomes with or without intraocular lens implantation from two tertiary centres in United Kingdom

    Chaitra Govardhan1, Ashwini Batchu Prithvi1, Bushra Aladaileh1, Elizabeth Cattermole2, Farrag Abdelsattar2, Catherine Guly2, Jessy Choi3, Johannes Keller2 and Athimalaipet V Ramanan1, 1Bristol Royal Hospital for Children, Bristol, United Kingdom, 2Bristol Eye Hospital, Bristol, United Kingdom, 3Sheffield Children's Hospital, Sheffield, United Kingdom

    Background/Purpose: Cataract is one of the most common and visually debilitating complications of paediatric uveitis developing as a consequence of chronic inflammation and steroid use.…
  • Abstract Number: 2446 • ACR Convergence 2025

    Use of Voclosporin in Pediatric Patients: A Summary of Available Data from Post-marketing Reports

    Eugenia Chock1, Ankana Daga2, Tasim Begum3, Kathryn Dao3 and Michelle Dardeno3, 1Yale School of Medicine, New Haven, CT, 2Boston Children's Hospital, Boston, MA, 3Aurinia Pharmaceuticals Inc., Rockville, MD

    Background/Purpose: Lupus nephritis (LN) is common in pediatric patients with systemic lupus erythematosus (SLE), with more than 50% developing renal manifestations, typically within the first…
  • Abstract Number: 2150 • ACR Convergence 2025

    Rheum to Grow:An Approach Towards Human Centered Design through a Qualitative Analysis on the Transition from Pediatric to Adult Rheumatology

    Lillian Chang1, Rhea Sharma2, Elyse Guziewicz1, Jordan Jackson3, Katrina Romagnoli1, Gemme Campbell1, Saritha Korukonda1, Priyanka Pawar1, Jonida Cote4, Thomas Davis1 and Emily Brunner1, 1Geisinger, Danville, PA, 2Geisinger Medical Center Internal Medicine Residency, Danville, PA, 3Geisinger Medical Center Medicine-Pediatrics Residency, Danville, PA, 4Geisinger Health System, Wilkes-Barre, PA

    Background/Purpose: Up to half of patients who transition to adult care are lost to follow up within 2 years of transfer from pediatric to adult…
  • Abstract Number: 2126 • ACR Convergence 2025

    Preliminary Results of a Large, Global Registry Characterizing Childhood-Onset Takayasu Arteritis

    Muserref Kasap Cuceoglu1, James Bistolarides2, Mario Sestan3, Samuel Gagne4, Nick McPhate5, Kimberly Morishita6, Vidya Sivaraman7, Linda Wagner-Weiner8, Seza Özen9, Marija Jelusic10 and David Cabral11, 1Hacettepe University, Ankara, Turkey, 2Medical College of Wisconsin, Wauwatosa, WI, 3University of Zagreb School of Medicine, Zagreb, Croatia, 4University of Pittsburgh, Pittsburgh, PA, 5BC Children's Hospital, Vancouver, Canada, 6University of British Columbia, Vancouver, BC, Canada, 7Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 8University of Chicago, Chicago, IL, 9Hacettepe University Medical Faculty, Ankara, Turkey, 10University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Zagreb, Croatia, 11BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: The rarity of childhood-onset Takayasu arteritis (c-TAK) has resulted in small cohorts for study that has limited the potential for evaluating its course and…
  • Abstract Number: 1810 • ACR Convergence 2025

    Destabilized Treg Cells Predominant in Severe Forms of Juvenile Idiopathic Arthritis

    Ki Pui Lam1, Claudia Harris2, Jennifer Cheng3, Lwiza AitDowd4, Maryam Ashoor5, Ahmad Bakhsh3, Carrie Bryant3, Siobhan Case6, Mia Chandler3, Joyce Chang3, Ezra Cohen7, Fatma Dedeoglu3, Olha Halyabar8, Jonathan Hausmann9, Melissa Hazen3, Sonia Iosim10, Liyoung Kim11, Jeffrey Lo3, Mindy Lo3, Emma Materne3, Esra Meidan12, Megan Perron13, Helene Powers10, Mary Beth Son3, Holly Wobma3, Margaret Chang3, Pui Lee14, Peter Nigrovic11 and Lauren Henderson15, 1Division of Immunology, Boston Childrens Hospital, Harvard Medical School, Boston, MA, 2Division of Immunology, Boston Childrens Hospital, Boston, MA, 3Boston Children's Hospital, Boston, MA, 4Boston Children's Hospital, Harvard Medical School, Boston, MA, 5Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Brookline, MA, 6UpToDate, Brigham and Women's Hospital, Boston Children's Hospital, Boston, MA, 7Bmc, NEEDHAM, MA, 8Children's Hospital/Boston Medical Center, Newton, MA, 9Boston Children's Hospital / Massachusetts General Hospital, Cambridge, MA, 10Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, 11Boston Children's Hospital, Brookline, MA, 12Boston Children's Hospital, Somerville, MA, 13Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Natick, MA, 14Boston Children's Hospital, Newton, MA, 15Boston Children's Hospital, Watertown, MA

    Background/Purpose: T peripheral helper (Tph) cells stimulate excessive B cell responses in the joints of patients with autoantibody-positive arthritis, including seropositive RA in adults and…
  • Abstract Number: 1575 • ACR Convergence 2025

    Clinical presentation, course, treatment and outcome of juvenile onset versus adult onset mixed connective tissue disease patients: a multicenter retrospective cohort.

    Kevin Chevalier1, Brigitte Bader-Meunier2, Isabelle Kone-Paut3, Benjamin Torreau4, Marc Michel5, Bertrand Godeau5, Christian AGARD6, Thomas Papo7, Karim Sacré8, Raphaele Seror9, Xavier Mariette10, Cacoub Patrice11, Ygal Benhamou12, Mathilde Leclercq13, Cécile goujard14, Olivier Lambotte3, Bernard Bonnotte15, Maxime Samson16, Félix Ackermann17, Jean Schmidt18, Pierre Duhaut18, Jean-Emmanuel Kahn19, Thomas Hanslik19, Nathalie Costedoat-Chalumeau20, Benjamin Terrier20, Alexis REGENT21, bertrand Dunogue22, Pascal Cohen23, Véronique Le Guern20, Eric HACHULLA24, Luc Mouthon22 and Benjamin Chaigne22, 1Université Paris Cité, Montrouge, France, 2Necker hospital, Paris, France, 3Bicêtre hospital, Kremlin Bicêtre, France, 4Internal Medicine and Immunology, CHU Tours, Tours, France, 5Henri Mondor hospital, Créteil, France, 6Internal medicine, Nantes University Hospital, Nantes, France, 7Bichat hospital, Paris, France, 8Department of Internal Medicine, Bichat University Hospital, Université Paris Cité, AP-HP, Paris, France, Paris, France, 9Department of Rheumatology, National referral center for auto immune disease and Sjogren disease, Université Paris-Saclay, INSERM UMR1184: Centre for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, Paris, France., le kremlin bicetre, France, 10Université Paris-Saclay, Le Kremlin Bicetre, France, 11Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre national de références Maladies Autoimmunes et systémiques rares, Centre national de références Maladies Autoinflammatoires rares et Amylose inflammatoire (CEREMAIA), INSERM, UMR S959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France, Paris, France, 12Internal Medicine, CHU Rouen, Rouen, France, 13Rouen hospital, Rouen, France, 14Université Paris Saclay, Department of Internal Medicine and Clinical Immunology, Bicêtre Hospital, APHP, UMR1184 Inserm, CEA, Le Kremlin Bicêtre, France, Kremlin Bicêtre, France, 15Internal medicine and clinical immunology, Université Bourgogne Europe , CHU Dijon Bourgogne, Dijon, France, 16CHU Dijon Bourgogne, Dijon, France, 17Foch hospital, Suresnes, France, 18Amiens hospital, Amiens, France, 19Ambroise Paré hospital, Boulogne, France, 20Cochin hospital, Paris, France, 21Hopital Cochin, Paris, France, 22Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP, Paris, France, 23Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France, 24CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes et Auto-Inflammatoires Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, France, Lille, France

    Background/Purpose: Mixed connective tissue disease (MCTD) is an entity defined by clinical features of differentiated connective tissue diseases (dCTD), such as systemic lupus erythematosus (SLE),…
  • Abstract Number: 1290 • ACR Convergence 2025

    Adverse Childhood Experiences: Prevalence and Relationship to Disease and Mental Health Outcomes in Childhood-Onset Systemic Lupus Erythematosus (cSLE)

    Jin Xuan Zhou1, Stephanie Fevrier2, Paris Moaf2, Lawrence Ng3, Asha Jeyanathan4, Louise Boulard2, Deborah Levy1, Linda Hiraki1, Ashley Danguecan5 and Andrea Knight5, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Hospital for Sick Children, Toronto, Canada, 3The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, Canada, 5Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) is an autoimmune disease characterized by multi-organ inflammation, alongside high frequencies of mood disorders and cognitive impairment. Adverse Childhood…
  • Abstract Number: 1273 • ACR Convergence 2025

    Effectiveness of IV Cyclophosphamide and Mycophenolate Mofetil in the Treatment of Pediatric Systemic Lupus Erythematosus with Lupus Nephritis

    adrienne katrin guiang-valerio, University of Santo Tomas Hospital, Mandaluyong, National Capital Region, Philippines

    Background/Purpose: Lupus nephritis (LN) is more common in children (occurs in 50-82%) compared to adults. Cyclophosphamide (CYC) and mycophenolate mofetil (MMF) are both treatment options…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 62
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology